Merck KGaA (OTCMKTS:MKKGY – Get Free Report) saw a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 75,400 shares, a decline of 25.1% from the May 15th total of 100,700 shares. Based on an average daily volume of 237,200 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.0% of the company’s shares are short sold.
Merck KGaA Stock Down 1.8%
Shares of OTCMKTS:MKKGY opened at $25.19 on Thursday. The company has a market capitalization of $16.28 billion, a price-to-earnings ratio of 11.93, a P/E/G ratio of 1.91 and a beta of 0.94. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.31 and a quick ratio of 0.83. The business’s 50-day moving average is $26.81 and its 200-day moving average is $28.14. Merck KGaA has a 1 year low of $24.32 and a 1 year high of $39.17.
Merck KGaA (OTCMKTS:MKKGY – Get Free Report) last announced its quarterly earnings data on Thursday, May 15th. The company reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.50 by $0.09. The company had revenue of $5.89 billion for the quarter, compared to the consensus estimate of $5.32 billion. Merck KGaA had a return on equity of 9.61% and a net margin of 13.23%. Equities research analysts predict that Merck KGaA will post 1.87 earnings per share for the current year.
Merck KGaA Increases Dividend
Merck KGaA Company Profile
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
See Also
- Five stocks we like better than Merck KGaA
- What Do S&P 500 Stocks Tell Investors About the Market?
- Cantor Boosts Rocket Lab Target to Street-High $35
- Business Services Stocks Investing
- Why Amazon Could Be About To Breakout To $250
- Using the MarketBeat Dividend Yield Calculator
- Chime’s Smart IPO: Half the Valuation, Double the Strength
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.